These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 11164384)

  • 1. Catalepsy induced by the 5-HT(1A) receptor antagonist WAY 100635 in rats pretreated with the selective serotonin reuptake inhibitor citalopram.
    Eltayb A; Svensson TH; Ahlenius S
    Eur J Pharmacol; 2001 Jan; 411(3):275-7. PubMed ID: 11164384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation with a 5-HT(1A), but not a 5-HT(1B) receptor antagonist critically depends on the dose of citalopram.
    Cremers TI; de Boer P; Liao Y; Bosker FJ; den Boer JA; Westerink BH; Wikström HV
    Eur J Pharmacol; 2000 May; 397(1):63-74. PubMed ID: 10844100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of WAY 100635 on antipsychotic-induced catalepsy in 5-HT depleted animals: a role for tonic activation of 5-HT(1A) receptors.
    Prinssen EP; Koek W; Kleven MS
    Eur J Pharmacol; 2000 Apr; 395(2):143-7. PubMed ID: 10794820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic-like effect by combined treatment with citalopram and WAY 100635: involvement of the 5-HT2C receptor.
    Eltayb A; Wadenberg ML; Schilström B; Svensson TH
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):405-10. PubMed ID: 16879758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 5-HT(1A) receptor antagonist robalzotan completely reverses citalopram-induced inhibition of serotonergic cell firing.
    Arborelius L; Wallsten C; Ahlenius S; Svensson TH
    Eur J Pharmacol; 1999 Oct; 382(2):133-8. PubMed ID: 10528148
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined administration of 5-HT1A or 5-HT1B/1D receptor antagonists and antidepressants in the forced swimming test.
    Tatarczyńska E; Kłodzińska A; Stachowicz K; Chojnacka-Wójcik E
    Eur J Pharmacol; 2004 Mar; 487(1-3):133-42. PubMed ID: 15033385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic actions of the 5-HT1A receptor antagonist WAY-100635 and citalopram on male rat ejaculatory behavior.
    Ahlenius S; Larsson K
    Eur J Pharmacol; 1999 Aug; 379(1):1-6. PubMed ID: 10499366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute and chronic effects of citalopram on postsynaptic 5-hydroxytryptamine(1A) receptor-mediated feedback: a microdialysis study in the amygdala.
    Bosker FJ; Cremers TI; Jongsma ME; Westerink BH; Wikström HV; den Boer JA
    J Neurochem; 2001 Mar; 76(6):1645-53. PubMed ID: 11259482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Citalopram-induced hypophagia is enhanced by blockade of 5-HT(1A) receptors: role of 5-HT(2C) receptors.
    Grignaschi G; Invernizzi RW; Fanelli E; Fracasso C; Caccia S; Samanin R
    Br J Pharmacol; 1998 Aug; 124(8):1781-7. PubMed ID: 9756397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 5-HT1A receptor-mediated serotonin augmentation on Fos immunoreactivity in rat brain.
    Jongsma ME; Sebens JB; Bosker FJ; Korf J
    Eur J Pharmacol; 2002 Nov; 455(2-3):109-15. PubMed ID: 12445576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction studies of 5-HT1A receptor antagonists and selective 5-HT reuptake inhibitors in isolated aggressive mice.
    Sànchez C
    Eur J Pharmacol; 1997 Sep; 334(2-3):127-32. PubMed ID: 9369340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats.
    Cousins MS; Seiden LS
    Psychopharmacology (Berl); 2000 Mar; 148(4):438-42. PubMed ID: 10928318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delta(9)-tetrahydrocannabinol prolongs the immobility time in the mouse forced swim test: involvement of cannabinoid CB(1) receptor and serotonergic system.
    Egashira N; Matsuda T; Koushi E; Higashihara F; Mishima K; Chidori S; Hasebe N; Iwasaki K; Nishimura R; Oishi R; Fujiwara M
    Eur J Pharmacol; 2008 Jul; 589(1-3):117-21. PubMed ID: 18565508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological characterisation of the decrease in 5-HT synthesis in the mouse brain evoked by the selective serotonin re-uptake inhibitor citalopram.
    Stenfors C; Yu H; Ross SB
    Naunyn Schmiedebergs Arch Pharmacol; 2001 Feb; 363(2):222-32. PubMed ID: 11218075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pindolol, a putative 5-hydroxytryptamine(1A) antagonist, does not reverse the inhibition of serotonergic neuronal activity induced by fluoxetine in awake cats: comparison to WAY-100635.
    Fornal CA; Martin FJ; Metzler CW; Jacobs BL
    J Pharmacol Exp Ther; 1999 Oct; 291(1):220-8. PubMed ID: 10490908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Venlafaxine and its interaction with WAY 100635: effects on serotonergic unit activity and behavior in cats.
    Bjorvatn B; Fornal CA; Martín FJ; Metzler CW; Jacobs BL
    Eur J Pharmacol; 2000 Sep; 404(1-2):121-32. PubMed ID: 10980270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential potentiation of the effects of serotonin uptake inhibitors by 5-HT1A receptor antagonists in the dorsal raphe pathway: role of somatodendritic autoreceptors.
    Romero L; Artigas F
    J Neurochem; 1997 Jun; 68(6):2593-603. PubMed ID: 9166757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoreceptor antagonists enhance the effect of the reuptake inhibitor citalopram on extracellular 5-HT: this effect persists after repeated citalopram treatment.
    Gundlah C; Hjorth S; Auerbach SB
    Neuropharmacology; 1997; 36(4-5):475-82. PubMed ID: 9225272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of the bimodal antidepressant vilazodone: evidence for serotonin1A-receptor-mediated auto-augmentation of extracellular serotonin output.
    van Amsterdam C; Seyfried CA
    Psychopharmacology (Berl); 2014 Jun; 231(12):2547-58. PubMed ID: 24419272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of fluoxetine-induced penile erections by combined blockade of 5-HT1A and 5-HT1B receptors.
    Millan MJ; Perrin-Monneyron S
    Eur J Pharmacol; 1997 Mar; 321(3):R11-3. PubMed ID: 9085055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.